Marietta Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,875
Closed -$479K 102
2020
Q2
$479K Sell
4,875
-441
-8% -$38.8K 0.16% 87
2020
Q1
$405K Buy
+5,316
New +$453K 0.16% 92
2019
Q3
Sell
-9,480
Closed -$689K 118
2019
Q2
$689K Buy
9,480
+285
+3% +$22.4K 0.27% 78
2019
Q1
$741K Buy
9,195
+83
+0.9% +$6.79K 0.3% 73
2018
Q4
$840K Sell
9,112
-77
-0.8% -$6.77K 0.4% 72
2018
Q3
$869K Buy
9,189
+274
+3% +$26K 0.38% 74
2018
Q2
$826K Buy
8,915
+1,157
+15% +$113K 0.4% 77
2018
Q1
$734K Sell
7,758
-499
-6% -$54.8K 0.39% 72
2017
Q4
$799K Sell
8,257
-1,658
-17% -$156K 0.43% 69
2017
Q3
$881K Sell
9,915
-54
-0.5% -$4.11K 0.49% 68
2017
Q2
$723K Sell
9,969
-2,924
-23% -$197K 0.44% 72
2017
Q1
$840K Sell
12,893
-19,379
-60% -$1.22M 0.56% 66
2016
Q4
$2.02M Buy
+32,272
New +$1.97M 1.62% 13

Other funds holding ABBV

Marietta Wealth Management's ABBV Position: Q3 2020 in Review

Marietta Wealth Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 4,875 shares — an estimated $479K sold.

Marietta Wealth Management first reported a position in ABBV in Q4 2016 and held it in 13 quarters. The position peaked at $2.02M in Q4 2016. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Marietta Wealth Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Marietta Wealth Management sold 4,875 AbbVie shares in Q3 2020, an estimated $479K.
  • Marietta Wealth Management first reported a position in AbbVie in Q4 2016 and held it in 13 quarters.
  • Marietta Wealth Management's AbbVie position peaked at $2.02M in Q4 2016.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Marietta Wealth Management's 13F filing for Q3 2020, filed 4 Nov 2020.